Russia
In April, Russia approved a plan for the country’s biotechnology industry from 2012 through 2020, with the goal of its bioeconomy’s volume totaling 1% of GDP by 2020 and 3% of GDP by 2030. The plan specifies a RUB 1.2 trillion ($39 billion) investment in the sector over the next eight years, of which 32%, 18% and 17% would be allocated for bio-energy, industrial biotech, and agricultural and food biotech, respectively. The plan consists of two four-year phases. Stage I would focus on creating domestic demand, increasing exports, and the development of capabilities for both biological synthesis and biofuels, including investments in infrastructure and research capacity. Stage II would focus on modernizing biotech production methods, industrialization and research integration, including investments in production and product financing. The document also lays out requirements for developing biotech education, research, production, centers of expertise, collaboration, regional support and infrastructure.
Source: US Department of Agriculture